Skip to main content
Year archive

MESOBLAST LTD — 2016 filings

All 97 regulatory filings released by MESOBLAST LTD (MESO) in 2016, sourced directly from the official regulator.

97 Filings
2016 Period
2016 filings (97)
Filing Released Lang
6-K MALLINCKRODT
Foreign Filer Report
2016-12-23 English
Mesoblast And Mallinckrodt Enter Into Agreement 2 pages 101.0KB
Regulatory Filings
2016-12-22 English
6-K-US LEGISLATION ASX ANNOUNCEMENT
Foreign Filer Report
2016-12-13 English
S&P DJ Indices Announces December Quarterly Rebalance 3 pages 108.6KB
Regulatory Filings
2016-12-08 English
New US Accelerated Approval Pathway For Cell Therapies 2 pages 96.2KB
Regulatory Filings
2016-12-08 English
6-K
Foreign Filer Report
2016-12-08 English
MD Anderson and NIH Fund Trial Using Mesoblast Technologies 2 pages 101.3KB
Regulatory Filings
2016-12-05 English
Chairman's Address to Shareholders 1 page 271.5KB
Regulatory Filings
2016-11-21 English
CEO Presentation to 2016 Annual General Meeting 32 pages 957.6KB
Regulatory Filings
2016-11-21 English
Results of Meeting 2 pages 171.8KB
Regulatory Filings
2016-11-21 English
6-K
Foreign Filer Report
2016-11-15 English
MESO-Q1FY17-30SEP2016
Foreign Filer Report
2016-11-14 English
First Quarter Results On Form 6K 108 pages 2.1MB
Regulatory Filings
2016-11-14 English
First Quarter Results Presentation 27 pages 569.7KB
Regulatory Filings
2016-11-14 English
Mesoblast Provides Corporate Update and Q1 Financial Results 7 pages 211.7KB
Regulatory Filings
2016-11-14 English
Successful Interim Futility Analysis In P3 Trial for GVHD 3 pages 113.2KB
Regulatory Filings
2016-11-13 English
6-K APPENDIX 4C
Foreign Filer Report
2016-11-03 English
Appendix 4C - quarterly 5 pages 61.0KB
Regulatory Filings
2016-10-30 English
6-K
Foreign Filer Report
2016-10-26 English
Appendix 4G And Corporate Governance Statement 20 pages 179.3KB
Regulatory Filings
2016-10-20 English
Notice of Annual General Meeting/Proxy Form 14 pages 298.8KB
Regulatory Filings
2016-10-20 English
Annual Report to shareholders 201 pages 6.3MB
Regulatory Filings
2016-10-20 English
6-K
Foreign Filer Report
2016-10-19 English
Mesoblast Receives Frost & Sullivan 2016 Cell Therapy Award 2 pages 110.5KB
Regulatory Filings
2016-10-17 English
6-K AJBC ANNOUNCEMENT
Foreign Filer Report
2016-10-13 English
MSB Japan Strategy Highlighted At Business Council Meeting 2 pages 95.4KB
Regulatory Filings
2016-10-11 English
6-K DIABETIC KIDNEY DISEASE PHASE II TRIAL RESULTS
Foreign Filer Report
2016-10-11 English
Mesoblast Phase 2 Diabetic Kidney Disease Results Published 3 pages 124.2KB
Regulatory Filings
2016-10-05 English
6-K
Foreign Filer Report
2016-09-01 English
Mesoblast Appoints Bill Burns As Vice Chairman 2 pages 91.1KB
Regulatory Filings
2016-08-31 English
6-K
Foreign Filer Report
2016-08-26 English
20-F
Annual Report FY 2016
2016-08-25 English
Preliminary Final Report (Including Appendix 4E) 242 pages 5.9MB
Regulatory Filings
2016-08-24 English
Annual Financial Results Presentation 31 pages 679.3KB
Regulatory Filings
2016-08-24 English
Mesoblast Reports on Annual and Fourth Quarter Results 9 pages 215.9KB
Regulatory Filings
2016-08-24 English
Appendix 3B 8 pages 184.8KB
Regulatory Filings
2016-08-18 English
6-K RHEUMATIC CONDITIONS PRESS RELEASE
Foreign Filer Report
2016-08-18 English
MSB Strengthens US Patent Portfolio For Rheumatic Diseases 3 pages 136.9KB
Regulatory Filings
2016-08-16 English
6-K
Foreign Filer Report
2016-08-10 English
Presentation On Mesoblast RA P2 Trial Results 20 pages 2.0MB
Regulatory Filings
2016-08-08 English
Mesoblast P2 Results Show Dose-Related Improvements In RA 5 pages 166.6KB
Regulatory Filings
2016-08-08 English
FORM 6-K INCORPORATING APPENDIX 4C - QUARTERLY REPORT FOR THE QUARTER ENDED JUNE
Foreign Filer Report
2016-08-02 English
MSB Back Pain Results Presented, Receive Best Science Award 3 pages 140.4KB
Regulatory Filings
2016-07-31 English
Appendix 4C - quarterly 5 pages 173.0KB
Regulatory Filings
2016-07-28 English
FORM 6-K
Foreign Filer Report
2016-07-01 English
Update on Heart Failure Trial and Funding of Operations 3 pages 126.1KB
Regulatory Filings
2016-06-30 English
FORM 6-K
Foreign Filer Report
2016-06-15 English
Update on Global Heart Failure Program 3 pages 130.4KB
Regulatory Filings
2016-06-13 English
Reinstatement to Official Quotation 1 page 253.9KB
Regulatory Filings
2016-06-13 English
Extension of Voluntary Suspension 1 page 63.6KB
Regulatory Filings
2016-06-09 English
Suspension from Official Quotation 2 pages 333.3KB
Regulatory Filings
2016-06-02 English
Trading Halt 2 pages 334.9KB
Regulatory Filings
2016-05-31 English
FORM 6-K
Foreign Filer Report
2016-05-24 English
Mesoblast Receives $6.2m From Aus Govt For R&D 1 pa
Regulatory Filings
2016-05-19 English
Ceasing to be a substantial holder-JP Morgan 15 pages 1.4MB
Regulatory Filings
2016-05-12 English
Change in substantial holding 11 pages 566.5KB
Regulatory Filings
2016-05-11 English
Ceasing to be a substantial holder 8 pages 454.7KB
Regulatory Filings
2016-05-11 English
6-K
Foreign Filer Report
2016-05-10 English
Third Quarter Financial Results On Form 6-K 110 pages 1.9MB
Regulatory Filings
2016-05-09 English
Third Quarter Results Presentation 24 pages 3.8MB
Regulatory Filings
2016-05-09 English
Mesoblast Provides Q3 Financial Results and Corporate Update 8 pages 320.1KB
Regulatory Filings
2016-05-09 English
Change in substantial holding 39 pages 3.9MB
Regulatory Filings
2016-05-08 English
Change in substantial holding-J.P.Morgan 23 pages 3.0MB
Regulatory Filings
2016-05-08 English
FORM 6-K
Foreign Filer Report
2016-04-29 English
Appendix 3B and Prospectus for Issue of Employee Options 52 pages 526.5KB
Regulatory Filings
2016-04-27 English
Appendix 4C - quarterly 5 pages 172.6KB
Regulatory Filings
2016-04-27 English
FORM S-8
Registration Form
2016-04-26 English
FORM 6-K
Foreign Filer Report
2016-04-22 English
Release of Shares from Voluntary Escrow 1 page 88.4
Regulatory Filings
2016-04-18 English
MESOBLAST LIMITED
Major Shareholding Notification
2016-04-12 English
MESOBLAST LIMITED
Major Shareholding Notification
2016-04-12 English
6-K
Foreign Filer Report
2016-04-02 English
Mesoblast Cells Show Disease Modifying Effects on Knee OA 3 pages 168.5KB
Regulatory Filings
2016-03-31 English
FORM 6-K
Foreign Filer Report
2016-03-25 English
Key US Patent Granted For Treatment Of Rheumatoid Arthritis 2 pages 137.8KB
Regulatory Filings
2016-03-23 English
FORM 6-K
Foreign Filer Report
2016-03-17 English
Mesoblast Technology Shows Potential In Type 1 Diabetes 2 pages 126.7KB
Regulatory Filings
2016-03-16 English
6-K
Foreign Filer Report
2016-02-26 English
Appendix 3B 8 pages 270.4KB
Regulatory Filings
2016-02-25 English
GVHD Product Launched In Japan 2 pages 91.6KB
Regulatory Filings
2016-02-23 English
Increased Survival Using MSB Cells In Children With aGVHD 2 pages 137.3KB
Regulatory Filings
2016-02-21 English
FORM 6-K
Foreign Filer Report
2016-02-17 English
6-K
Foreign Filer Report
2016-02-16 English
SC 13G
Major Shareholding Notification
2016-02-16 English
Half Yearly Report and Accounts (including Appendix 4D) 118 pages 4.0MB
Regulatory Filings
2016-02-16 English
Half Year Results Presentation 18 pages 601.4KB
Regulatory Filings
2016-02-16 English
Mesoblast Reports on First Half and Second Quarter Results 7 pages 975.6KB
Regulatory Filings
2016-02-16 English
MSB Therapy Shows Benefit In First Cohort Of RA Patients 2 pages 134.2KB
Regulatory Filings
2016-02-15 English
SC 13G
Major Shareholding Notification
2016-02-12 English
FORM 6-K
Foreign Filer Report
2016-02-01 English
Appendix 4C - quarterly 5 pages 971.2KB
Regulatory Filings
2016-01-27 English
FORM 6-K
Foreign Filer Report
2016-01-19 English
Change in substantial holding 40 pages 5.1MB
Regulatory Filings
2016-01-18 English
CEO Presentation at JP Morgan Healthcare Conference 32 pages 6.8MB
Regulatory Filings
2016-01-13 English
FORM 6-K
Foreign Filer Report
2016-01-12 English
Phase 3 Heart Failure Trial Size Substantially Reduced 2 pages 111.5KB
Regulatory Filings
2016-01-10 English
Mesoblast to Present at J.P. Morgan Healthcare Conference 1
Regulatory Filings
2016-01-07 English